Skip to main content
Erschienen in: Digestive Diseases and Sciences 9/2009

01.09.2009 | Review

Gastric Hyperplastic Polyps: A Review

verfasst von: Richa Jain, Runjan Chetty

Erschienen in: Digestive Diseases and Sciences | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

Hyperplastic polyps represent the commonest polyp encountered in the stomach. They occur in patients of either gender and are commoner in the seventh decade of life. They are usually asymptomatic, small (less than 1 cm in diameter), solitary lesions occurring in the antrum but can present with dyspepsia, heartburn, abdominal pain, or upper gastrointestinal (GI) bleeding leading to anemia. Hyperplastic polyps almost never occur in normal gastric mucosa and are most commonly associated with chronic gastritis (Helicobacter pylori or autoimmune-induced). Pathologically, they are characterized by dilated, tortuous gastric foveoli set within an inflamed, edematous stroma. There is considerable histologic overlap especially with Ménétrier’s disease and hamartomatous (juvenile or retention) polyps, and clinical input is mandatory to accomplish separation of these entities. Hyperplastic polyps arise as a by-product of repair to damaged mucosa. Dysplasia and malignancy are rarely associated with these polyps, which show an array of molecular aberrations. The importance of hyperplastic polyps for both gastroenterologist and pathologist lies in their association with other gastric mucosal pathology and mandates biopsy of adjacent mucosa and diligent search for accompanying pathology by the pathologist.
Literatur
3.
Zurück zum Zitat Sanna CM, Loriga P, Dessi E, et al. Hyperplastic polyp of the stomach simulating hypertrophic pyloric stenosis. J Pediatr Gastrenterol Nutr. 1991;13:204–208. Sanna CM, Loriga P, Dessi E, et al. Hyperplastic polyp of the stomach simulating hypertrophic pyloric stenosis. J Pediatr Gastrenterol Nutr. 1991;13:204–208.
4.
Zurück zum Zitat Yao T, Kajiwara M, Kuroiwa S, et al. Malignant transformation of gastric hyperplastic polyps: Alteration of phenotypes, proliferative activity, and p53 expression. Hum Pathol. 2002;33:1016–1022.PubMedCrossRef Yao T, Kajiwara M, Kuroiwa S, et al. Malignant transformation of gastric hyperplastic polyps: Alteration of phenotypes, proliferative activity, and p53 expression. Hum Pathol. 2002;33:1016–1022.PubMedCrossRef
5.
Zurück zum Zitat Murakami K, Mitomi H, Yamashita K, Tanabe S, Saigenji K, Okayasu I. p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Am J Clin Pathol. 2001;115:224–234.PubMedCrossRef Murakami K, Mitomi H, Yamashita K, Tanabe S, Saigenji K, Okayasu I. p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Am J Clin Pathol. 2001;115:224–234.PubMedCrossRef
6.
Zurück zum Zitat Al-Haddad M, Ward EM, Bouras EP, Raimondo M. Hyperplastic polyps of the gastric antrum in patients with gastrointestinal blood loss. Dig Dis Sci. 2007;52:105–109.PubMedCrossRef Al-Haddad M, Ward EM, Bouras EP, Raimondo M. Hyperplastic polyps of the gastric antrum in patients with gastrointestinal blood loss. Dig Dis Sci. 2007;52:105–109.PubMedCrossRef
8.
Zurück zum Zitat Abraham SC. Gastric polyps: Classification and meaning. Pathol Case Rev. 2002;7:2–11.CrossRef Abraham SC. Gastric polyps: Classification and meaning. Pathol Case Rev. 2002;7:2–11.CrossRef
9.
Zurück zum Zitat Burke AP, Sobin LH. The pathology of Cronkhite-Canada polyps: A comparison to juvenile polyposis. Am J Surg Pathol. 1989;13:940–946.PubMedCrossRef Burke AP, Sobin LH. The pathology of Cronkhite-Canada polyps: A comparison to juvenile polyposis. Am J Surg Pathol. 1989;13:940–946.PubMedCrossRef
10.
Zurück zum Zitat Stolte M, Bethke B, Sticht T, Burkhard U. Differentiation of focal foveolar hyperplasia from hyperplastic polyps in gastric biopsy material. Path Res Pract. 1995;191:1198–1202.PubMed Stolte M, Bethke B, Sticht T, Burkhard U. Differentiation of focal foveolar hyperplasia from hyperplastic polyps in gastric biopsy material. Path Res Pract. 1995;191:1198–1202.PubMed
11.
Zurück zum Zitat Rubio CA, Ost A, Kato Y, Yanagisawa A, Rivera F, Hirota T. Hyperplastic foveolar gastropathies and hyperplastic foveolar gastritis. APMIS. 1997;105:784–792.PubMedCrossRef Rubio CA, Ost A, Kato Y, Yanagisawa A, Rivera F, Hirota T. Hyperplastic foveolar gastropathies and hyperplastic foveolar gastritis. APMIS. 1997;105:784–792.PubMedCrossRef
12.
Zurück zum Zitat Orlowska J, Jarasz D, Pachlewski J, Butruk E. Malignant transformation of benign epithelial gastric polyps. Am J Gastroenterol. 1995;90:2152–2159.PubMed Orlowska J, Jarasz D, Pachlewski J, Butruk E. Malignant transformation of benign epithelial gastric polyps. Am J Gastroenterol. 1995;90:2152–2159.PubMed
13.
Zurück zum Zitat Ji F, Wang Z, Ning J, Wang Q, Chen J, Li Y. Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: A randomized, controlled trial. World J Gastroenterol. 2006;12:1770–1773.PubMed Ji F, Wang Z, Ning J, Wang Q, Chen J, Li Y. Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: A randomized, controlled trial. World J Gastroenterol. 2006;12:1770–1773.PubMed
14.
Zurück zum Zitat Bamba H, Ota S, Arai S, et al. Expression of cyclooxygenase-2 in human hyperplastic gastric polyps. J Exp Clin Cancer Res. 2003;22:425–430.PubMed Bamba H, Ota S, Arai S, et al. Expression of cyclooxygenase-2 in human hyperplastic gastric polyps. J Exp Clin Cancer Res. 2003;22:425–430.PubMed
15.
Zurück zum Zitat Nakajima A, Matsuhashi N, Yazaki Y, Oka T, Sugano K. Details of hyperplastic polyps of the stomach shrinking after anti-Helicobacter pylori therapy. J Gastroenterol. 2000;35:372–375.PubMedCrossRef Nakajima A, Matsuhashi N, Yazaki Y, Oka T, Sugano K. Details of hyperplastic polyps of the stomach shrinking after anti-Helicobacter pylori therapy. J Gastroenterol. 2000;35:372–375.PubMedCrossRef
16.
Zurück zum Zitat Kume K, Hirakoba M, Murata I, Yoshikawa I, Otsuki M. Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori. Am J Gastroenterol. 2001;96:2796–2797.PubMedCrossRef Kume K, Hirakoba M, Murata I, Yoshikawa I, Otsuki M. Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori. Am J Gastroenterol. 2001;96:2796–2797.PubMedCrossRef
17.
Zurück zum Zitat Tanaka J, Fujimoto K, Iwakiri R, et al. Hyperplastic polyps following treatment of acute gastric ulcers. Intern Med. 1994;33:366–368.PubMedCrossRef Tanaka J, Fujimoto K, Iwakiri R, et al. Hyperplastic polyps following treatment of acute gastric ulcers. Intern Med. 1994;33:366–368.PubMedCrossRef
18.
Zurück zum Zitat Niv Y, Delpre G, Sperber AD, Sandbank J, Zirkin H. Hyperplastic gastric polyposis, hypergastrinaemia and colorectal neoplasia: A description of four cases. Eur J Gastroenterol Hepatol. 2003;15:1361–1366.PubMedCrossRef Niv Y, Delpre G, Sperber AD, Sandbank J, Zirkin H. Hyperplastic gastric polyposis, hypergastrinaemia and colorectal neoplasia: A description of four cases. Eur J Gastroenterol Hepatol. 2003;15:1361–1366.PubMedCrossRef
19.
Zurück zum Zitat Amaro R, Neff GW, Karnam US, Tzakis AG, Raskin JB. Acquired hyperplastic gastric polyps in solid organ transplant patients. Am J Gastroenterol. 2002;97:2220–2224.PubMedCrossRef Amaro R, Neff GW, Karnam US, Tzakis AG, Raskin JB. Acquired hyperplastic gastric polyps in solid organ transplant patients. Am J Gastroenterol. 2002;97:2220–2224.PubMedCrossRef
20.
Zurück zum Zitat Jewell KD, Toweill DL, Swanson PE, Upton MP, Yeh MM. Gastric hyperplastic polyps in post transplant patients: A clinicopathologic study. Mod Pathol. 2008;21:1108–1112.PubMedCrossRef Jewell KD, Toweill DL, Swanson PE, Upton MP, Yeh MM. Gastric hyperplastic polyps in post transplant patients: A clinicopathologic study. Mod Pathol. 2008;21:1108–1112.PubMedCrossRef
21.
Zurück zum Zitat Daibo M, Itabashi M, Hirota T. Malignant transformation of gastric hyperplastic polyps. Am J Gastroenterol. 1987;82:1016–1025.PubMed Daibo M, Itabashi M, Hirota T. Malignant transformation of gastric hyperplastic polyps. Am J Gastroenterol. 1987;82:1016–1025.PubMed
22.
Zurück zum Zitat Nogueira AMMF, Carneiro F, Seruca R, et al. Microsatellite instability in hyperplastic and adenomatous polyps of the stomach. Cancer. 1999;86:1649–1656.PubMedCrossRef Nogueira AMMF, Carneiro F, Seruca R, et al. Microsatellite instability in hyperplastic and adenomatous polyps of the stomach. Cancer. 1999;86:1649–1656.PubMedCrossRef
23.
Zurück zum Zitat Hattori T. Morphological range of hyperplastic polyps and carcinomas arising in hyperplastic polyps of the stomach. J Clin Pathol. 1985;38:622–630.PubMedCrossRef Hattori T. Morphological range of hyperplastic polyps and carcinomas arising in hyperplastic polyps of the stomach. J Clin Pathol. 1985;38:622–630.PubMedCrossRef
24.
Zurück zum Zitat Zea-Iriarte WL, Sekine I, Itsuno M, et al. Carcinoma in gastric hyperplastic polyps: A phenotypic study. Dig Dis Sci. 1996;41:377–386.PubMedCrossRef Zea-Iriarte WL, Sekine I, Itsuno M, et al. Carcinoma in gastric hyperplastic polyps: A phenotypic study. Dig Dis Sci. 1996;41:377–386.PubMedCrossRef
25.
Zurück zum Zitat Dirschmid K, Platz-Baudin C, Stolte M. Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? Virchows Arch. 2006;448:80–84.PubMedCrossRef Dirschmid K, Platz-Baudin C, Stolte M. Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? Virchows Arch. 2006;448:80–84.PubMedCrossRef
26.
Zurück zum Zitat Hirano H, Yoshida T, Yoshimura H, et al. Poorly differentiated adenocarcinoma with signet-ring cell carcinoma in a hyperplastic polyp of the stomach: Report of a case. Surg Today. 2007;37:901–904.PubMedCrossRef Hirano H, Yoshida T, Yoshimura H, et al. Poorly differentiated adenocarcinoma with signet-ring cell carcinoma in a hyperplastic polyp of the stomach: Report of a case. Surg Today. 2007;37:901–904.PubMedCrossRef
27.
Zurück zum Zitat Hirasaki S, Suzuki S, Kanzaki H, Fujita K, Matsumura S, Matsumoto E. Minute signet ring cell carcinoma occurring in gastric hyperplastic polyp. World J Gastroenterol. 2007;13:5779–5780.PubMed Hirasaki S, Suzuki S, Kanzaki H, Fujita K, Matsumura S, Matsumoto E. Minute signet ring cell carcinoma occurring in gastric hyperplastic polyp. World J Gastroenterol. 2007;13:5779–5780.PubMed
28.
Zurück zum Zitat Wu CH, Chen MJ, Chang WH, Chan YJ, Wang HY, Shih SC. Signet-ring type adenocarcinoma arising from a tiny gastric polyp. Gastrointest Endosc. 2008;67:724–725.PubMedCrossRef Wu CH, Chen MJ, Chang WH, Chan YJ, Wang HY, Shih SC. Signet-ring type adenocarcinoma arising from a tiny gastric polyp. Gastrointest Endosc. 2008;67:724–725.PubMedCrossRef
29.
Zurück zum Zitat Dijkhuizen SMM, Entius MM, Clement MJ, et al. Multiple hyperplastic polyps in the stomach: Evidence for clonality and neoplastic potential. Gastroenterology. 1997;112:561–566.PubMedCrossRef Dijkhuizen SMM, Entius MM, Clement MJ, et al. Multiple hyperplastic polyps in the stomach: Evidence for clonality and neoplastic potential. Gastroenterology. 1997;112:561–566.PubMedCrossRef
30.
Zurück zum Zitat Lauwers GY, Wahl SJ, Melamed J, Rojas-Corona RR. p53 expression in precancerous gastric lesions: an immunohistochemical study of Pab 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. Am J Gastroenterol. 1993;88:1916–1919.PubMed Lauwers GY, Wahl SJ, Melamed J, Rojas-Corona RR. p53 expression in precancerous gastric lesions: an immunohistochemical study of Pab 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. Am J Gastroenterol. 1993;88:1916–1919.PubMed
31.
Zurück zum Zitat Weiss MM, Kuipers EJ, Postma C, Snijders AM, Stolte M, et al. Genome wide array comparative genomic hybridisation analysis of premalignant lesions of the stomach. Mol Pathol. 2003;56:293–298.PubMedCrossRef Weiss MM, Kuipers EJ, Postma C, Snijders AM, Stolte M, et al. Genome wide array comparative genomic hybridisation analysis of premalignant lesions of the stomach. Mol Pathol. 2003;56:293–298.PubMedCrossRef
32.
Zurück zum Zitat Seruca R, Carneiro F, Castedo S, David L, Lopes C, Sobrinho-Simoes M. Familial gastric polyposis revisited: Autosomal dominant inheritance confirmed. Cancer Genet Cytogenet. 1991;53:97–100.PubMedCrossRef Seruca R, Carneiro F, Castedo S, David L, Lopes C, Sobrinho-Simoes M. Familial gastric polyposis revisited: Autosomal dominant inheritance confirmed. Cancer Genet Cytogenet. 1991;53:97–100.PubMedCrossRef
33.
Zurück zum Zitat Carneiro F, David L, Seruca R, Castedo S, Nesland JM, Sobrinho-Simoes M. Hyperplastic polyposis and diffuse carcinoma of the stomach: A study of a family. Cancer. 1993;72:323–329.PubMedCrossRef Carneiro F, David L, Seruca R, Castedo S, Nesland JM, Sobrinho-Simoes M. Hyperplastic polyposis and diffuse carcinoma of the stomach: A study of a family. Cancer. 1993;72:323–329.PubMedCrossRef
34.
Zurück zum Zitat Davion T, Lescanne-Darchis I, Maunoury V, et al. Hyperplastic gastric polyposis and familial colonic adenomas. Apropos of a case. Gastroenterol Clin Biol 1996;20:298–302. Davion T, Lescanne-Darchis I, Maunoury V, et al. Hyperplastic gastric polyposis and familial colonic adenomas. Apropos of a case. Gastroenterol Clin Biol 1996;20:298–302.
35.
Zurück zum Zitat Mochizuka A, Uehara T, Nakamura T, Kobayashi Y, Ota H. Hyperplastic polyps and sessile serrated ‘adenomas’ of the colon and rectum display gastric pyloric differentiation. Histochem Cell Biol. 2007;128:445–455.PubMedCrossRef Mochizuka A, Uehara T, Nakamura T, Kobayashi Y, Ota H. Hyperplastic polyps and sessile serrated ‘adenomas’ of the colon and rectum display gastric pyloric differentiation. Histochem Cell Biol. 2007;128:445–455.PubMedCrossRef
36.
Zurück zum Zitat Owens SR, Chiosea SI, Kuan SF. Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod Pathol. 2008;21:660–669.PubMedCrossRef Owens SR, Chiosea SI, Kuan SF. Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod Pathol. 2008;21:660–669.PubMedCrossRef
37.
Zurück zum Zitat Yao T, Nishiyama KI, Oya M, Kouzuki T, Kajiwara M, Tsuneyoshi M. Multiple serrated adenocarcinomas of the colon with a cell lineage common to metaplastic polyp and serrated adenoma: Case report of a new subtype of colonic adenocarcinoma with gastric differentiation. J Pathol. 2000;190:444–449.PubMedCrossRef Yao T, Nishiyama KI, Oya M, Kouzuki T, Kajiwara M, Tsuneyoshi M. Multiple serrated adenocarcinomas of the colon with a cell lineage common to metaplastic polyp and serrated adenoma: Case report of a new subtype of colonic adenocarcinoma with gastric differentiation. J Pathol. 2000;190:444–449.PubMedCrossRef
38.
Zurück zum Zitat Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP. Serrated polyps of the large intestine: A morphologic and molecular review of an evolving concept. Am J Clin Pathol. 2005;124:380–391.PubMedCrossRef Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP. Serrated polyps of the large intestine: A morphologic and molecular review of an evolving concept. Am J Clin Pathol. 2005;124:380–391.PubMedCrossRef
39.
Zurück zum Zitat Liang JJ, Alrawi S, Tan D. Nomenclature, molecular genetics and clinical significance of the precursor lesions in the serrated polyp pathway of colorectal carcinoma. Int J Clin Exp Pathol. 2008;1:317–324.PubMed Liang JJ, Alrawi S, Tan D. Nomenclature, molecular genetics and clinical significance of the precursor lesions in the serrated polyp pathway of colorectal carcinoma. Int J Clin Exp Pathol. 2008;1:317–324.PubMed
Metadaten
Titel
Gastric Hyperplastic Polyps: A Review
verfasst von
Richa Jain
Runjan Chetty
Publikationsdatum
01.09.2009
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 9/2009
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0572-8

Weitere Artikel der Ausgabe 9/2009

Digestive Diseases and Sciences 9/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.